Xponential Health (NYSE:XPOF – Get Score) had its goal value lifted by equities analysis analysts at B. Riley from $30.00 to $32.00 in a analysis observe issued to traders on Friday, The Fly experiences. B. Riley’s value goal would point out a possible upside of 24.85% from the corporate’s present value.
Plenty of different analysts have additionally weighed in on XPOF. Raymond James upped their value goal on Xponential Health from $29.00 to $30.00 and gave the inventory a “strong-buy” ranking in a analysis report on Friday, November eleventh. Morgan Stanley upped their value goal on Xponential Health from $25.00 to $26.00 and gave the inventory an “chubby” ranking in a analysis report on Friday, November eleventh. Guggenheim upped their value goal on Xponential Health to $26.00 in a analysis report on Wednesday, November sixteenth. Citigroup assumed protection on Xponential Health in a analysis report on Tuesday, December sixth. They set a “purchase” ranking and a $29.00 goal value on the inventory. Lastly, Piper Sandler upped their value goal on Xponential Health from $34.00 to $36.00 and gave the inventory an “chubby” ranking in a analysis report on Friday, November eleventh. Six analysis analysts have rated the inventory with a purchase ranking and one has assigned a robust purchase ranking to the corporate’s inventory. In line with information from MarketBeat, the inventory has a consensus ranking of “Purchase” and a median goal value of $30.63.
Xponential Health Inventory Down 2.3%
NYSE:XPOF opened at $25.63 on Friday. The inventory’s fifty day transferring common is $21.87 and its two-hundred day transferring common is $18.87. Xponential Health has a 52 week low of $11.20 and a 52 week excessive of $26.90. The inventory has a market capitalization of $1.26 billion, a price-to-earnings ratio of -5.14, a price-to-earnings-growth ratio of 1.12 and a beta of 1.32.
Xponential Health (NYSE:XPOF – Get Score) final launched its quarterly earnings outcomes on Thursday, November tenth. The corporate reported $0.10 EPS for the quarter, lacking analysts’ consensus estimates of $0.12 by ($0.02). Xponential Health had a damaging return on fairness of 28.11% and a damaging web margin of 5.65%. The agency had income of $63.76 million for the quarter, in comparison with analyst estimates of $55.15 million. On common, sell-side analysts count on that Xponential Health will publish 0.06 EPS for the present fiscal 12 months.
Insider Exercise at Xponential Health
In associated information, EVP Megan Moen bought 4,633 shares of the inventory in a transaction on Thursday, November seventeenth. The inventory was bought at a median value of $22.17, for a complete worth of $102,713.61. Following the transaction, the chief vice chairman now owns 36,659 shares of the corporate’s inventory, valued at $812,730.03. The transaction was disclosed in a submitting with the Securities & Alternate Fee, which is accessible by way of this hyperlink. Insiders have bought 15,933 shares of firm inventory valued at $346,058 over the past quarter. 69.33% of the inventory is owned by insiders.
Hedge Funds Weigh In On Xponential Health
A number of massive traders have not too long ago purchased and bought shares of XPOF. Amalgamated Financial institution acquired a brand new place in Xponential Health within the first quarter valued at $32,000. Macquarie Group Ltd. boosted its stake in Xponential Health by 133.2% within the second quarter. Macquarie Group Ltd. now owns 2,696 shares of the corporate’s inventory valued at $34,000 after buying an extra 1,540 shares within the final quarter. Point72 Hong Kong Ltd acquired a brand new place in Xponential Health within the second quarter valued at $34,000. Hillsdale Funding Administration Inc. acquired a brand new place in Xponential Health within the third quarter valued at $82,000. Lastly, American Worldwide Group Inc. boosted its stake in shares of Xponential Health by 29.8% through the second quarter. American Worldwide Group Inc. now owns 7,939 shares of the corporate’s inventory value $100,000 after shopping for an extra 1,824 shares through the interval. Institutional traders and hedge funds personal 28.77% of the corporate’s inventory.
Xponential Health Firm Profile
Xponential Health, Inc, by way of its subsidiaries, operates as a boutique health franchiser in the US and internationally. The corporate affords health and wellness companies, together with pilates, barre, biking, stretching, rowing, yoga, boxing, dancing, operating, and practical coaching beneath the Membership Pilates, Pure Barre, CycleBar, StretchLab, Row Home, YogaSix, Rumble, AKT , Stride, and BFT manufacturers.
This on the spot information alert was generated by narrative science expertise and monetary information from MarketBeat so as to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial staff previous to publication. Please ship any questions or feedback about this story to firstname.lastname@example.org.
Earlier than you think about Xponential Health, you may need to hear this.
MarketBeat retains monitor of Wall Avenue’s top-rated and greatest performing analysis analysts and the shares they suggest to their purchasers every day. MarketBeat has recognized the 5 shares that high analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and Xponential Health wasn’t on the listing.
Whereas Xponential Health at the moment has a “Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.
View The 5 Shares Right here